Telix Pharmaceuticals Ltd reported -44291000 in EBITDA for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Cochlear COH:AU $ 258.8M 53.6M
CSL CSL:AU $ 2.66B 1.45B
Integral Diagnostics Ltd IDX:AU 32.01M 4.51M
Mayne Pharma MYX:AU $ 24.88M 7.38M
Pacific Edge PEB:NZ -10164000 1.28M
Paradigm Biopharmaceuticals Ltd PAR:AU -26873800 13.43M
Polynovo Ltd PNV:AU -1851160 213.7K
PYC Therapeutics Ltd PYC:AU -6063890 12.25M
Ramsay Health Care RHC:AU $ 773.1M 44.8M
ResMed RMD:AU $ 276.57M 12.93M
Sonic Healthcare SHL:AU $ 1.54B 281.03M